M. Michelle Berrey - 14 Jun 2021 Form 3 Insider Report for INTERCEPT PHARMACEUTICALS, INC.

Role
President, R&D and CMO
Signature
/s/ Mary J. Grendell, as attorney-in-fact
Issuer symbol
N/A
Transactions as of
14 Jun 2021
Net transactions value
$0
Form type
3
Filing time
15 Jun 2021, 19:00:30 UTC
Next filing
31 Jan 2022
SEC
View on sec.gov

No securities are beneficially owned.

Remarks:

Exhibit List - Exhibit 24.1 - Power of Attorney